Full Text View
Tabular View
No Study Results Posted
Related Studies
Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community
This study has been completed.
Study NCT00126386   Information provided by Alberta Health Services

First Received on August 2, 2005.   Last Updated on November 18, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cancer
Hypercalcemia
Pain
More general conditions related to this trial
Calcium Metabolism Disorders
Metabolic Diseases
Water-Electrolyte Imbalance
Interventions listed in this trial
Zoledronic acid (Zometa)
Additional drug interventions recognized in this trial
Diphosphonates
Zoledronic acid
More general drug interventions related to this trial
Bone Density Conservation Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Alberta Health Services


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services